共 50 条
- [11] Intrinsic and acquired resistance to CDK4/6 inhibitors and potential overcoming strategiesACTA PHARMACOLOGICA SINICA, 2021, 42 (02) : 171 - 178Xu, Xia-qing论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Inst Pharmacol & Toxicol, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou 310058, Peoples R China Zhejiang Univ, Inst Pharmacol & Toxicol, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou 310058, Peoples R ChinaPan, Xiao-hui论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Inst Pharmacol & Toxicol, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou 310058, Peoples R China Zhejiang Univ, Inst Pharmacol & Toxicol, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou 310058, Peoples R ChinaWang, Ting-ting论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Inst Pharmacol & Toxicol, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou 310058, Peoples R China Zhejiang Univ, Inst Pharmacol & Toxicol, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou 310058, Peoples R ChinaWang, Jian论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Inst Pharmacol & Toxicol, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou 310058, Peoples R China Zhejiang Univ, Inst Pharmacol & Toxicol, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou 310058, Peoples R ChinaYang, Bo论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Inst Pharmacol & Toxicol, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou 310058, Peoples R China Zhejiang Univ, Inst Pharmacol & Toxicol, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou 310058, Peoples R ChinaHe, Qiao-jun论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Inst Pharmacol & Toxicol, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou 310058, Peoples R China Zhejiang Univ, Inst Pharmacol & Toxicol, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou 310058, Peoples R ChinaDing, Ling论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Inst Pharmacol & Toxicol, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou 310058, Peoples R China Zhejiang Univ, Inst Pharmacol & Toxicol, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou 310058, Peoples R China
- [12] Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistancePLOS ONE, 2020, 15 (01):O'Keefe, Rachel A.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USABhola, Neil E.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USALee, David S.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USAJohnson, Daniel E.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USAGrandis, Jennifer R.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA
- [13] Overcoming Acquired Resistance to Afatinib in HCC827, a Non-small Cell Lung Cancer Cell LineEUROPEAN JOURNAL OF CANCER, 2012, 48 : 47 - 48Hsu, J.论文数: 0 引用数: 0 h-index: 0Lin, W.论文数: 0 引用数: 0 h-index: 0Lien, T.论文数: 0 引用数: 0 h-index: 0Chang, W.论文数: 0 引用数: 0 h-index: 0Sun, M.论文数: 0 引用数: 0 h-index: 0Jiang, S.论文数: 0 引用数: 0 h-index: 0Yen, K.论文数: 0 引用数: 0 h-index: 0Chao, Y.论文数: 0 引用数: 0 h-index: 0
- [14] Differential Cross resistance profiles of Head and Neck Carcinoma Cell lines with acquired resistance to Cisplatin and CetuximabSTRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 : 13 - 14Niehr, F.论文数: 0 引用数: 0 h-index: 0机构: Charite, Klin Radioonkol & Strahlentherapie, Translat Forschungslab Radioonkol, D-13353 Berlin, Germany Charite, Klin Radioonkol & Strahlentherapie, Translat Forschungslab Radioonkol, D-13353 Berlin, GermanyBoyko-Fabian, M.论文数: 0 引用数: 0 h-index: 0机构: Charite, Klin Radioonkol & Strahlentherapie, Translat Forschungslab Radioonkol, D-13353 Berlin, Germany Charite, Klin Radioonkol & Strahlentherapie, Translat Forschungslab Radioonkol, D-13353 Berlin, GermanyBudach, V论文数: 0 引用数: 0 h-index: 0机构: Charite, Klin Radioonkol & Strahlentherapie, Translat Forschungslab Radioonkol, D-13353 Berlin, Germany Charite, Klin Radioonkol & Strahlentherapie, Translat Forschungslab Radioonkol, D-13353 Berlin, GermanyTinhofer-Keilholz, I论文数: 0 引用数: 0 h-index: 0机构: Charite, Klin Radioonkol & Strahlentherapie, Translat Forschungslab Radioonkol, D-13353 Berlin, Germany Charite, Klin Radioonkol & Strahlentherapie, Translat Forschungslab Radioonkol, D-13353 Berlin, Germany
- [15] Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistanceJournal of Cancer Research and Clinical Oncology, 2023, 149 : 669 - 682Lucien Torlot论文数: 0 引用数: 0 h-index: 0机构: Ludwig-Maximilians-University (LMU),Institute of PathologyAnna Jarzab论文数: 0 引用数: 0 h-index: 0机构: Ludwig-Maximilians-University (LMU),Institute of PathologyJohanna Albert论文数: 0 引用数: 0 h-index: 0机构: Ludwig-Maximilians-University (LMU),Institute of PathologyÁgnes Pók-Udvari论文数: 0 引用数: 0 h-index: 0机构: Ludwig-Maximilians-University (LMU),Institute of PathologyArndt Stahler论文数: 0 引用数: 0 h-index: 0机构: Ludwig-Maximilians-University (LMU),Institute of PathologyJulian Walter Holch论文数: 0 引用数: 0 h-index: 0机构: Ludwig-Maximilians-University (LMU),Institute of PathologyMarco Gerlinger论文数: 0 引用数: 0 h-index: 0机构: Ludwig-Maximilians-University (LMU),Institute of PathologyVolker Heinemann论文数: 0 引用数: 0 h-index: 0机构: Ludwig-Maximilians-University (LMU),Institute of PathologyFrederick Klauschen论文数: 0 引用数: 0 h-index: 0机构: Ludwig-Maximilians-University (LMU),Institute of PathologyThomas Kirchner论文数: 0 引用数: 0 h-index: 0机构: Ludwig-Maximilians-University (LMU),Institute of PathologyJörg Kumbrink论文数: 0 引用数: 0 h-index: 0机构: Ludwig-Maximilians-University (LMU),Institute of PathologyBernhard Küster论文数: 0 引用数: 0 h-index: 0机构: Ludwig-Maximilians-University (LMU),Institute of PathologyAndreas Jung论文数: 0 引用数: 0 h-index: 0机构: Ludwig-Maximilians-University (LMU),Institute of Pathology
- [16] Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistanceJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (02) : 669 - 682Torlot, Lucien论文数: 0 引用数: 0 h-index: 0机构: Ludwig Maximilians Univ LMU, Inst Pathol, Munich, Germany German Canc Consortium DKTK, Heidelberg, Munich Site, Germany Ludwig Maximilians Univ LMU, Inst Pathol, Munich, GermanyJarzab, Anna论文数: 0 引用数: 0 h-index: 0机构: Tech Univ Munich, Chair Prote & Bioanalyt, Freising Weihenstephan, Germany Ludwig Maximilians Univ LMU, Inst Pathol, Munich, GermanyAlbert, Johanna论文数: 0 引用数: 0 h-index: 0机构: Ludwig Maximilians Univ LMU, Inst Pathol, Munich, Germany Ludwig Maximilians Univ LMU, Inst Pathol, Munich, GermanyPok-Udvari, Agnes论文数: 0 引用数: 0 h-index: 0机构: Ludwig Maximilians Univ LMU, Inst Pathol, Munich, Germany Ludwig Maximilians Univ LMU, Inst Pathol, Munich, GermanyStahler, Arndt论文数: 0 引用数: 0 h-index: 0机构: Charite Univ Med Berlin, Dept Hematol Oncol & Canc Immunol, Berlin, Germany Free Univ Berlin, Berlin, Germany Humboldt Univ, Berlin, Germany German Canc Consortium DKTK, Berlin, Germany Ludwig Maximilians Univ LMU, Inst Pathol, Munich, GermanyHolch, Julian Walter论文数: 0 引用数: 0 h-index: 0机构: German Canc Consortium DKTK, Heidelberg, Munich Site, Germany LMU Hosp, Dept Med 3, Munich, Germany LMU Hosp, Comprehens Canc Ctr Munich CCCM, Munich, Germany Ludwig Maximilians Univ LMU, Inst Pathol, Munich, GermanyGerlinger, Marco论文数: 0 引用数: 0 h-index: 0机构: Inst Canc Res, Translat Oncogen Lab, London, England Queen Mary Univ London, Barts Canc Inst, London, England St Bartholomews Hosp, Gastrointestinal Canc Unit, London, England Ludwig Maximilians Univ LMU, Inst Pathol, Munich, GermanyHeinemann, Volker论文数: 0 引用数: 0 h-index: 0机构: German Canc Consortium DKTK, Heidelberg, Munich Site, Germany LMU Hosp, Dept Med 3, Munich, Germany LMU Hosp, Comprehens Canc Ctr Munich CCCM, Munich, Germany Ludwig Maximilians Univ LMU, Inst Pathol, Munich, GermanyKlauschen, Frederick论文数: 0 引用数: 0 h-index: 0机构: Ludwig Maximilians Univ LMU, Inst Pathol, Munich, Germany German Canc Consortium DKTK, Heidelberg, Munich Site, Germany LMU Hosp, Comprehens Canc Ctr Munich CCCM, Munich, Germany Ludwig Maximilians Univ LMU, Inst Pathol, Munich, GermanyKirchner, Thomas论文数: 0 引用数: 0 h-index: 0机构: Ludwig Maximilians Univ LMU, Inst Pathol, Munich, Germany German Canc Consortium DKTK, Heidelberg, Munich Site, Germany LMU Hosp, Comprehens Canc Ctr Munich CCCM, Munich, Germany Ludwig Maximilians Univ LMU, Inst Pathol, Munich, GermanyKumbrink, Joerg论文数: 0 引用数: 0 h-index: 0机构: Ludwig Maximilians Univ LMU, Inst Pathol, Munich, Germany German Canc Consortium DKTK, Heidelberg, Munich Site, Germany LMU Hosp, Comprehens Canc Ctr Munich CCCM, Munich, Germany Ludwig Maximilians Univ LMU, Inst Pathol, Munich, GermanyKuester, Bernhard论文数: 0 引用数: 0 h-index: 0机构: German Canc Consortium DKTK, Heidelberg, Munich Site, Germany Tech Univ Munich, Chair Prote & Bioanalyt, Freising Weihenstephan, Germany Ludwig Maximilians Univ LMU, Inst Pathol, Munich, GermanyJung, Andreas论文数: 0 引用数: 0 h-index: 0机构: Ludwig Maximilians Univ LMU, Inst Pathol, Munich, Germany German Canc Consortium DKTK, Heidelberg, Munich Site, Germany LMU Hosp, Comprehens Canc Ctr Munich CCCM, Munich, Germany Ludwig Maximilians Univ LMU, Inst Pathol, Munich, Germany
- [17] Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patientsScientific Reports, 9Steven M. Bray论文数: 0 引用数: 0 h-index: 0机构: Lilly Research Laboratories,Eli Lilly and CompanyJeeyun Lee论文数: 0 引用数: 0 h-index: 0机构: Lilly Research Laboratories,Eli Lilly and CompanySeung Tae Kim论文数: 0 引用数: 0 h-index: 0机构: Lilly Research Laboratories,Eli Lilly and CompanyJoon Young Hur论文数: 0 引用数: 0 h-index: 0机构: Lilly Research Laboratories,Eli Lilly and CompanyPhilip J. Ebert论文数: 0 引用数: 0 h-index: 0机构: Lilly Research Laboratories,Eli Lilly and CompanyJohn N. Calley论文数: 0 引用数: 0 h-index: 0机构: Lilly Research Laboratories,Eli Lilly and CompanyIsabella H. Wulur论文数: 0 引用数: 0 h-index: 0机构: Lilly Research Laboratories,Eli Lilly and CompanyThejaswini Gopalappa论文数: 0 引用数: 0 h-index: 0机构: Lilly Research Laboratories,Eli Lilly and CompanySwee Seong Wong论文数: 0 引用数: 0 h-index: 0机构: Lilly Research Laboratories,Eli Lilly and CompanyHui-Rong Qian论文数: 0 引用数: 0 h-index: 0机构: Lilly Research Laboratories,Eli Lilly and CompanyJason C. Ting论文数: 0 引用数: 0 h-index: 0机构: Lilly Research Laboratories,Eli Lilly and CompanyJiangang Liu论文数: 0 引用数: 0 h-index: 0机构: Lilly Research Laboratories,Eli Lilly and CompanyMelinda D. Willard论文数: 0 引用数: 0 h-index: 0机构: Lilly Research Laboratories,Eli Lilly and CompanyRuslan D. Novosiadly论文数: 0 引用数: 0 h-index: 0机构: Lilly Research Laboratories,Eli Lilly and CompanyYoung Suk Park论文数: 0 引用数: 0 h-index: 0机构: Lilly Research Laboratories,Eli Lilly and CompanyJoon Oh Park论文数: 0 引用数: 0 h-index: 0机构: Lilly Research Laboratories,Eli Lilly and CompanyHo Yeong Lim论文数: 0 引用数: 0 h-index: 0机构: Lilly Research Laboratories,Eli Lilly and CompanyWon Ki Kang论文数: 0 引用数: 0 h-index: 0机构: Lilly Research Laboratories,Eli Lilly and CompanyAmit Aggarwal论文数: 0 引用数: 0 h-index: 0机构: Lilly Research Laboratories,Eli Lilly and CompanyHee Cheol Kim论文数: 0 引用数: 0 h-index: 0机构: Lilly Research Laboratories,Eli Lilly and CompanyChristoph Reinhard论文数: 0 引用数: 0 h-index: 0机构: Lilly Research Laboratories,Eli Lilly and Company
- [18] Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patientsSCIENTIFIC REPORTS, 2019, 9 (1)Bray, Steven M.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USALee, Jeeyun论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol, Seoul, South Korea Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USAKim, Seung Tae论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol, Seoul, South Korea Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USA论文数: 引用数: h-index:机构:Ebert, Philip J.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USACalley, John N.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USAWulur, Isabella H.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USAGopalappa, Thejaswini论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USAWong, Swee Seong论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USAQian, Hui-Rong论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USATing, Jason C.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USALiu, Jiangang论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USAWillard, Melinda D.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USANovosiadly, Ruslan D.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USAPark, Young Suk论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol, Seoul, South Korea Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USA论文数: 引用数: h-index:机构:Lim, Ho Yeong论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol, Seoul, South Korea Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USAKang, Won Ki论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol, Seoul, South Korea Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USAAggarwal, Amit论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USAKim, Hee Cheol论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USAReinhard, Christoph论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USA
- [19] Biomarkers of resistance to cetuximab in head and neck squamous cell carcinoma (HNSCC).JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)Surikova, Ekaterina I.论文数: 0 引用数: 0 h-index: 0机构: Rostov Res Inst Oncol, Rostov Na Donu, Russia Rostov Res Inst Oncol, Rostov Na Donu, RussiaKit, Oleg I.论文数: 0 引用数: 0 h-index: 0机构: Rostov Res Inst Oncol, Rostov Na Donu, Russia Rostov Res Inst Oncol, Rostov Na Donu, RussiaNeskubina, Irina V.论文数: 0 引用数: 0 h-index: 0机构: Rostov Res Inst Oncol, Rostov Na Donu, Russia Rostov Res Inst Oncol, Rostov Na Donu, RussiaFrantsiyants, Elena M.论文数: 0 引用数: 0 h-index: 0机构: Rostov Res Inst Oncol, Rostov Na Donu, Russia Rostov Res Inst Oncol, Rostov Na Donu, RussiaVladimirova, Liubov Yu论文数: 0 引用数: 0 h-index: 0机构: Rostov Res Inst Oncol, Rostov Na Donu, Russia Rostov Res Inst Oncol, Rostov Na Donu, RussiaLyanova, Aza A.论文数: 0 引用数: 0 h-index: 0机构: Rostov Res Inst Oncol, Rostov Na Donu, Russia Rostov Res Inst Oncol, Rostov Na Donu, RussiaEngibaryan, Marina A.论文数: 0 引用数: 0 h-index: 0机构: Rostov Res Inst Oncol, Rostov Na Donu, Russia Rostov Res Inst Oncol, Rostov Na Donu, RussiaShalashnaya, Elena V.论文数: 0 引用数: 0 h-index: 0机构: Rostov Res Inst Oncol, Rostov Na Donu, Russia Rostov Res Inst Oncol, Rostov Na Donu, RussiaAedinova, Irina V.论文数: 0 引用数: 0 h-index: 0机构: Rostov Res Inst Oncol, Rostov Na Donu, Russia Rostov Res Inst Oncol, Rostov Na Donu, RussiaUlianova, Yulia V.论文数: 0 引用数: 0 h-index: 0机构: Rostov Res Inst Oncol, Rostov Na Donu, Russia Rostov Res Inst Oncol, Rostov Na Donu, RussiaVolkova, Viktoriya L.论文数: 0 引用数: 0 h-index: 0机构: Rostov Res Inst Oncol, Rostov Na Donu, Russia Rostov Res Inst Oncol, Rostov Na Donu, RussiaPustovaya, Irina Viktorovna论文数: 0 引用数: 0 h-index: 0机构: Rostov Res Inst Oncol, Rostov Na Donu, Russia Rostov Res Inst Oncol, Rostov Na Donu, RussiaEzhova, Maria论文数: 0 引用数: 0 h-index: 0机构: Rostov Res Inst Oncol, Rostov Na Donu, Russia Rostov Res Inst Oncol, Rostov Na Donu, Russia
- [20] PTEN and cetuximab resistance in head and neck squamous cell carcinoma (HNSCC).JOURNAL OF CLINICAL ONCOLOGY, 2017, 35Da Costa, Alexandre Andre B. A.论文数: 0 引用数: 0 h-index: 0机构: AC Camargo Canc Ctr, Sao Paulo, BrazilCosta, Felipe D'Almeida论文数: 0 引用数: 0 h-index: 0机构: AC Camargo Canc Ctr, Sao Paulo, BrazilDe Oliveira, Andrea Cruz Ferraz论文数: 0 引用数: 0 h-index: 0机构: AC Camargo Canc Ctr, Sao Paulo, BrazilStecca, Carlos论文数: 0 引用数: 0 h-index: 0机构: AC Camargo Canc Ctr, Sao Paulo, BrazilOliveira, Audrey论文数: 0 引用数: 0 h-index: 0机构: AC Camargo Canc Ctr, Sao Paulo, BrazilAlves, Ana Caroline Fonseca论文数: 0 引用数: 0 h-index: 0机构: AC Camargo Canc Ctr, Sao Paulo, BrazilCamandaroba, Marcos Pedro Guedes论文数: 0 引用数: 0 h-index: 0机构: AC Camargo Canc Ctr, Sao Paulo, BrazilAraujo, Daniel Vilarim论文数: 0 引用数: 0 h-index: 0机构: AC Camargo Canc Ctr, Sao Paulo, BrazilMachado, Larissa论文数: 0 引用数: 0 h-index: 0机构: AC Camargo Canc Ctr, Sao Paulo, BrazilDe Lima, Vladmir Claudio Cordeiro论文数: 0 引用数: 0 h-index: 0机构: AC Camargo Canc Ctr, Sao Paulo, Brazil